123-I mIBG (AdreView) Heart-to-Mediastinal (H/M) Ratio and SPECT Imaging on a Small Field of View-High Efficiency Cardiac SPECT System
NCT ID: NCT01868841
Last Updated: 2018-01-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
45 participants
INTERVENTIONAL
2013-12-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
123I-mIBG SPECT Imaging
NCT02043522
Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI
NCT01373944
Cadmium-zinc-telluride (CZT) Imaging of Myocardial Blood Flow (MBF) (SPECT MBF)
NCT02280941
xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease
NCT04583787
Comparison Between Myocardial Tomoscintigraphies Using a Semiconductor Camera or a Conventional Camera
NCT02861235
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adreview LFOV SPECT Imaging followed by SFOV-HE Imaging
SPECT imaging of 10 millicurie of Adreview
AdreView
10 millicurie of AdreView (123I-mIBG)
Single Photon Emission Computed Tomography
AdreView SFOV-HE SPECT Imaging followed by LFOV Imaging
SPECT imaging of 10 millicurie of Adreview
AdreView
10 millicurie of AdreView (123I-mIBG)
Single Photon Emission Computed Tomography
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AdreView
10 millicurie of AdreView (123I-mIBG)
Single Photon Emission Computed Tomography
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Left ventricular ejection fraction less than or equal to 35%
Exclusion Criteria
* Recent hospitalization within 30 days of cardiac related indications
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GE Healthcare
INDUSTRY
Timothy M. Bateman
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Timothy M. Bateman
Medical Director
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Timothy M Bateman, MD
Role: PRINCIPAL_INVESTIGATOR
Aspire Foundation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cardiovascular Imaging Technologies
Kansas City, Missouri, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-039
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.